Skip to content
Open access

Leveraging expression quantitative trait loci information in single-cell resolution to identify cell-specific genes for Basal cell carcinoma

Aug 2026 · PLoS ONE · Vol 21, pp. e0354887 · 0 citations · 38 references
Medicine

TL;DR

The authors' exploratory scTWAS using healthy donor PBMC-derived eQTLs uncovered cell-type-specific BCC associations missed by bulk analyses, providing hypothesis-generating insights into immune-related genetic effects in BCC, demonstrating how single-cell resolution can overcome signal dilution from cellular heterogeneity.

Abstract

Background Basal cell carcinoma (BCC), the most common skin cancer, is driven by UV-induced DNA damage and shaped by immune surveillance. Although GWAS has identified over 140 risk loci, their cell-type-specific effects remain obscured by tissue-level averaging. Methods We integrated BCC GWAS summary statistics from a UK-based cohort (17,416 cases, 375,455 controls) with single-cell expression quantitative trait locus (sc-eQTL) data from 12 immune cell types in the OneK1K resource. Using the OTTERS framework combined with ACAT-O, we performed single-cell transcriptome-wide association analysis (scTWAS); bulk TWAS using GTEx whole blood served as a conventional tissue-averaged benchmark for comparison, rather than a definitive gold standard. Functional enrichment was conducted via Gene Ontology (GO). Results Bulk TWAS using GTEx whole blood identified 35 BCC-associated genes (FDR < 0.05), including MC1R and CASP8. In contrast, single-cell transcriptome-wide association study (scTWAS) across 12 OneK1K cell types revealed 207 non-redundant susceptibility genes, predominantly in CD4ET, MONOC, and BIN. Functional enrichment uncovered cell-type-specific programs: MHC class II antigen presentation (CD4ET), PRR-mediated innate immunity (MONOC), and pro-inflammatory secretion (BIN)—all absent in bulk results. Conclusion Our exploratory scTWAS using healthy donor PBMC-derived eQTLs uncovered cell-type-specific BCC associations missed by bulk analyses, providing hypothesis-generating insights into immune-related genetic effects in BCC. This underscores how single-cell resolution can overcome signal dilution from cellular heterogeneity, though validation in tumor-derived immune populations is warranted.

Read PDF

Similar papers

Open access Aug 2026

Single-Cell RNA-Seq Reveals Chromosomal Instability-Associated Transcriptomic Profiles in Breast Cancer

Single-cell approaches such as scRNA-seq provide a powerful framework to elucidate CIN-related mechanisms and to identify potential biomarkers of BC aggressiveness and prognosis, supporting their further application in the study of intratumoral heterogeneity.

María Paula Meléndez-Flórez, N. Rangel, Milena Rondón-Lagos et al. · 0 citations
Open access Aug 2026

Single-cell transcriptomics deciphers cancer-associated fibroblast heterogeneity and immune regulatory mechanisms in the bladder cancer tumor microenvironment

Single-cell transcriptomics of publicly available BLCA data identifies two transcriptionally distinct fibroblast states in adjacent tissue and supports an exploratory ligand–receptor interaction framework, warranting prospective validation with primary CAF populations and adequately powered multi-specimen cohorts.

Yan-Dong He, Wen-Long Lu, Guan-Qun Ju et al. · 0 citations
Open access Sep 2026

Integration of bulk and single-cell transcriptomics with spatial analysis identifies candidate hub genes and inferred regulatory programs in atopic dermatitis

Cross-modal analyses linked candidate molecular signals todendritic-cell- and T- cell-associated patterns in AD and identified disease-severity-associated gene modules enriched in immune and cell-cycle-related processes.

Yuqing Chen, Yu-Long Pan, Jia-Jie Chen et al. · 0 citations
Open access Jan 2026

Integrated Bulk and Single‐Cell Transcriptomic Analyses Identify a Five‐Gene Signature Associated With Prognosis and the Tumor Microenvironment in Epstein–Barr Virus–Associated Gastric Cancer

A five‐gene signature with strong diagnostic value and biologically meaningful prognostic relevance in EBVaGC is identified, highlighting fibroblast‐ and B‐cell‐associated microenvironmental programs in aggressive disease.

Luyu Jin, Man Jiang, Yu-Long Pan et al. · 0 citations
Open access Sep 2026

Single-cell and bulk transcriptomic integration identifies a high-CNV, dark-zone-enriched malignant cell state associated with adverse prognosis in GCB-DLBCL.

BACKGROUND Germinal centre B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) generally has a better prognosis than activated B-cell-like DLBCL, yet a clinically significant subset of patients still develops aggressive disease, suggesting marked malignant cellular heterogeneity within this subtype. This study aimed...

Jia-Ning Wang, Xiu-Ying Xiang, Xiao-Mei He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.